Triaziquone: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{one source|date=September 2014}} {{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 448209127 | IUPAC_name = 2,3,5-tris(aziridin-1-yl)benzo-1,4...")
 
No edit summary
Line 67: Line 67:
{{Chemotherapeutic agents}}
{{Chemotherapeutic agents}}


[[Category:Aziridines]]
[[Category:drug]]
[[Category:Alkylating antineoplastic agents]]
[[Category:Benzoquinones]]

Revision as of 15:51, 6 April 2015

Triaziquone
Clinical data
Synonyms2,3,5-Tris(aziridin-1-yl)cyclohexa-2,5-diene-1,4-dione
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEBI
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC12H13N3O2
Molar mass231.25 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Triaziquone is a drug used in chemotherapy.

It is an alkylating agent.[1] It can react with DNA to form intrastrand crosslinks.[citation needed]

References

  1. Begleiter A (2000). "Clinical applications of quinone-containing alkylating agents". Front. Biosci. 5: E153–71. PMID 11056078.